Clinical trial
A Study to Determine the Ability of Folate Conjugates to Target Folate Receptors in Ovarian Cancer Tumors
NCT00003763 is registered in ClinicalTrials.gov with Endocyte as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Determine the Ability of Folate Conjugates to Target Folate Receptors in Ovarian Cancer Tumors
- Lead sponsor
- Endocyte
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 8, 1997
- Completion date
- May 3, 2000
- Enrollment
- 35 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer